These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4138325)

  • 1. Letter: In-vitro detection of hypersensitivity to antituberculous drugs.
    Baker JT; Pioli E; Williams WJ
    Lancet; 1974 Oct; 2(7886):967-9. PubMed ID: 4138325
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the treatment of tuberculosis.
    Clarke PD
    J R Nav Med Serv; 1976; 62(2):85-91. PubMed ID: 61273
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of tuberculosis in children.
    Durfee ML; Nemir RL; Sewell EM; Smith MH; Warren BJ; Hsu KH
    Am Rev Respir Dis; 1969 Feb; 99(2):304-7. PubMed ID: 5304707
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 5. The predictability of hypersensitivity to anti-tuberculous drugs.
    Thompson JE
    Aust N Z J Med; 1973 Jun; 3(3):239-44. PubMed ID: 4517219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial treatment of tuberculosis with rifampicin.
    O'Connell J; Campbell AH; Cowen K; Verins A
    Med J Aust; 1973 Nov; 2(19):881-5. PubMed ID: 4765873
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
    Baron DN; Bell JL
    Tubercle; 1974 Jun; 55(2):115-20. PubMed ID: 4620296
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of some antituberculous drugs upon the upper gastrointestinal tract: an experiment with para-aminosalicylic acid, isoniazid, and streptomycin.
    Varis K; Koskinen R; Jussila J; Rytömaa T; Tarpila S; Launiala K
    Scand J Gastroenterol; 1971; 6(7):589-95. PubMed ID: 5128066
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
    Averbakh MM; Keleberda KIa; Gergert VIa; Mingazitinova DM
    Probl Tuberk; 1980 Mar; (3):27-30. PubMed ID: 6994091
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis, prevention and early therapy of tuberculosis.
    Mayock RL; MacGregor RR
    Dis Mon; 1976 May; 22(8):1-60. PubMed ID: 817877
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of primary tuberculosis].
    Gerbeaux J
    Rev Med Liege; 1974 Jan; 29(2):29-35. PubMed ID: 4846950
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary tuberculosis.
    Stevenson DK
    Practitioner; 1974 Mar; 212(1269):321-6. PubMed ID: 4445072
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis.
    Citron KM
    Br Med J; 1973 May; 2(5861):296-8. PubMed ID: 4122247
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambulatory management of tuberculosis.
    Hampton JR; Bates JH
    Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.